Pharmaceutical Business Review
Anonymous User | Login

Dow To Streamline Manufacturing Footprint

Published: 02-Jul-2009

Calls for shutdown of a number of manufacturing assets, including ethylene and ethylene-derivative assets

The board of directors of Dow has approved a restructuring plan which calls for the shutdown of a number of manufacturing assets, including ethylene and ethylene-derivative assets in its basic portfolio.

Consistent with the company's $1.3 billion synergy commitment related to the acquisition of Rohm and Haas company, the restructuring plan includes a charge for the elimination of approximately 2,500 positions.

Dow would also recognize an impairment charge due to an expected loss on the divestiture of certain acrylic monomer and specialty latex assets, required for Federal Trade Commission approval of the Rohm and Haas acquisition.

Andrew Liveris, Chairman and CEO, Dow, said: Consistent with Dow's practice of active portfolio management, we continue to take quick and aggressive action to right-size our manufacturing footprint, particularly in our basics portfolio.

These actions are also aligned with our strategic transformation, which focuses on preferentially investing for growth in our performance and advanced materials portfolios. In addition, we are making excellent progress on achieving $1.3 billion in cost synergies from the acquisition, and today's steps demonstrate our speed and determination to deliver these savings, he added.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Almac

Drug Development Solutions ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

ADAPT Localization

The Translation and Localization Specialists ...

CurTec

Producer & Manufacturer of Plastics Packaging ...

Thomson Reuters

The World's Leading Source of Life Sciences Intelligent Information ...

Medilingua Translations

The Medical Translation Specialists ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

GRACO's New FDA Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New Hydra-Clean

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New 1590 & 3150 Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Customer Testimonial – Astra Zeneca

From the control room to the downstream processing area and with an eye on utilities servi ...

Hygienic Processing

From the control room to the downstream processing area and with an eye on utilities servi ...

Related Companies

No items to display

Suppliers Product News

Almac Completes Phase One of Its Expansion Plan to Pharma Services Facilities

New $15m facility will "meet growing business need for its integrated product development and commercial services."

Accovion Selects Liquent Insight Publisher

Contract Research Organization Chooses Thomson Reuters Software Solution

Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available

Free Access Given to Support the Global R&D and Healthcare Community

Thomson Reuters Announces the Availabilty of Three Pharma Matters Reports Covering January - March 2009

Quarterly Reports Use Market Intelligence and Competitive Analysis from Thomson Reuters to Highlight Developments in the Global Pharmaceutical Industry

Quality Control in Medical Translation

Various methods are available to ensure the quality of medical translations – but some are more effective than others.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address